Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. (IRWD) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · IRWD · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
20
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Ironwood Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
IRWD insider buying and selling by quarter
IRWD insider selling · IRWD insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · IRWD ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
IRWD executive sell shares · IRWD board member insider trading · IRWD insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 19, 2026 | Silver Ronald PFO & PAO | Award | 25,000 | — | Form 4 |
| Feb 24, 2026 | Shetzline Michael SVP, CMO, Head-Res&Drug | Sale | 17,012 | $62K | Form 4 |
Shetzline Michael
SVP, CMO, Head-Res&Drug
Date
Feb 24
Shares
17,012
Price
$3.66
Value
$62K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About IRWD insider trading
IRWD insider trades
Ironwood Pharmaceuticals, Inc. (IRWD) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Silver Ronald (PFO & PAO), Shetzline Michael (SVP, CMO, Head-Res&Drug). Over the past 12 months, 2 insiders have filed transactions with the SEC. IRWD insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Ironwood Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
IRWD insider trading · 5 questionsThe insiders of Ironwood Pharmaceuticals, Inc. (IRWD) include executives and directors such as Silver Ronald (PFO & PAO), Shetzline Michael (SVP, CMO, Head-Res&Drug), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026